The 2013 Canadian cardiovascular society heart failure management guidelines update: Focus on rehabilitation and exercise and surgical coronary revascularization

Canadian Journal of Cardiology

Volumn 30, Issue 3, 2014, Pages 249-263

  Moe, Gordon W ^a   Ezekowitz, Justin A ^b   O'Meara, Eileen ^c   Howlett, Jonathan G ^d   Fremes, Steve E ^e   Al Hesayen, Abdul ^a   Heckman, George A ^f   Ducharme, Anique ^c   Estrella Holder, Estrellita ^g   Grzeslo, Adam ^h,i   Harkness, Karen ⁱ   Lepage, Serge ^k   McDonald, Michael ^l   McKelvie, Robert S ⁱ   Nigam, Anil ^c   Rajda, Miroslaw ^m   Rao, Vivek ^l   Swiggum, Elizabeth ⁿ   Virani, Sean ^o   Van Le, Vy ^p   Zieroth, Shelley ^g   Arnold, J Malcolm O ^q   Ashton, Tom ^r   D'Astous, Michel ^s   Dorian, Paul ^a   Giannetti, Nadia ^t   Haddad, Haissam ^u   Isaac, Debra L ^d   Kouz, Simon ^j   Leblanc, Marie Hélène ^v   Liu, Peter ^u   Ross, Heather J ^l   Sussex, Bruce ^w   White, Michel ^c   more..

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF WATERLOO   (Canada)

^g ST BONIFACE GENERAL HOSPITAL   (Canada)

^h Joseph Brant Memorial Hospital Burlington   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j UNIVERSITÉ LAVAL   (Canada)

^k CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^l UNIVERSITY HEALTH NETWORK   (Canada)

^m DALHOUSIE UNIVERSITY   (Canada)

ⁿ ROYAL JUBILEE HOSPITAL   (Canada)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^p CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^q UNIVERSITY OF WESTERN ONTARIO   (Canada)

^r McGill University ^*

^s UNIVERSITÉ DE MONCTON   (Canada)

^t MCGILL UNIVERSITY   (Canada)

^u UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^v LAVAL UNIVERSITY   (Canada)

^w Health Sciences Centre St John's   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; CARDIOLOGY; DISEASE MANAGEMENT; EXERCISE THERAPY; HEART FAILURE; HUMANS; MYOCARDIAL REVASCULARIZATION; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84894287523     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.10.010     Document Type: Article

References (104)

1. Arnold J.M., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006, 22:23-45.
2. Arnold J.M., Howlett J.G., Dorian P., et al. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol 2007, 23:21-45.
3. Howlett J.G., McKelvie R.S., Arnold J.M., et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 2009, 25:85-105.
4. Howlett J.G., McKelvie R.S., Costigan J., et al. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol 2010, 26:185-202.
5. Malcom J., Arnold O., Howlett J.G., et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure-2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol 2008, 24:21-40.
6. McKelvie R.S., Moe G.W., Cheung A., et al. The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol 2011, 27:319-338.
7. McKelvie R.S., Moe G.W., Ezekowitz J.A., et al. The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 2013, 29:168-181.
8. McCormack J.P., Loewen P. Adding "value" to clinical practice guidelines. Can Fam Physician 2007, 53:1326-1327.
9. Vanhees L., Geladas N., Hansen D., et al. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR. Part II. Eur J Prev Cardiol 2012, 19:1005-1033.
10. Piepoli M.F. Exercise training in heart failure. Curr Heart Fail Rep 2006, 3:189-196.
11. O'Connor C.M., Whellan D.J., Lee K.L., et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009, 301:1439-1450.
12. Piepoli M.F., Davos C., Francis D.P., Coats A.J. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004, 328:189.
13. Smart N., Marwick T.H. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 2004, 116:693-706.
14. Flynn K.E., Pina I.L., Whellan D.J., et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009, 301:1451-1459.
15. Davies E.J., Moxham T., Rees K., et al. Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. Eur J Heart Fail 2010, 12:706-715.
16. Willenheimer R., Rydberg E., Cline C., et al. Effects on quality of life, symptoms and daily activity 6 months after termination of an exercise training programme in heart failure patients. Int J Cardiol 2001, 77:25-31.
17. Goodlin S.J. Palliative care in congestive heart failure. J Am Coll Cardiol 2009, 54:386-396.
18. McKelvie R.S. Exercise training in patients with heart failure: clinical outcomes, safety, and indications. Heart Fail Rev 2008, 13:3-11.
19. Fujimoto N., Prasad A., Hastings J.L., et al. Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fraction. Am Heart J 2012, 164:869-877.
20. Kitzman D.W., Brubaker P.H., Herrington D.M., et al. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. J Am Coll Cardiol 2013, 62:584-592.
21. Taylor R.S., Davies E.J., Dalal H.M., et al. Effects of exercise training for heart failure with preserved ejection fraction: a systematic review and meta-analysis of comparative studies. Int J Cardiol 2012, 162:6-13.
22. Heran B.S., Chen J.M., Ebrahim S., et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011, CD001800.
23. McKelvie R.S., Komajda M., McMurray J., et al. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial. J Card Fail 2010, 16:128-134.
24. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362:777-781.
25. Isaksen K., Morken I.M., Munk P.S., Larsen A.I. Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation. Eur J Prev Cardiol 2012, 19:804-812.
26. Vanhees L., Rauch B., Piepoli M., et al. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (part III). Eur J Prev Cardiol 2012, 19:1333-1356.
27. Vanhees L., Kornaat M., Defoor J., et al. Effect of exercise training in patients with an implantable cardioverter defibrillator. Eur Heart J 2004, 25:1120-1126.
28. Harkness K., Heckman G.A., McKelvie R.S. The older patient with heart failure: high risk for frailty and cognitive impairment. Expert Rev Cardiovasc Ther 2012, 10:779-795.
29. Dafoe W., Arthur H., Stokes H., Morrin L., Beaton L. Universal access: but when? Treating the right patient at the right time: access to cardiac rehabilitation. Can J Cardiol 2006, 22:905-911.
30. Grace S.L., Shanmugasegaram S., Gravely-Witte S., et al. Barriers to cardiac rehabilitation: does age make a difference?. J Cardiopulm Rehabil Prev 2009, 29:183-187.
31. Theou O., Stathokostas L., Roland K.P., et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res 2011, 2011:569194.
32. Inouye S.K., Bogardus S.T., Charpentier P.A., et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999, 340:669-676.
33. Rizzo J.A., Bogardus S.T., Leo-Summers L., et al. Multicomponent targeted intervention to prevent delirium in hospitalized older patients: what is the economic value?. Med Care 2001, 39:740-752.
34. Rubin F.H., Neal K., Fenlon K., Hassan S., Inouye S.K. Sustainability and scalability of the hospital elder life program at a community hospital. J Am Geriatr Soc 2011, 59:359-365.
35. Cheetham C., Green D., Collis J., Dembo L., O'Driscoll G. Effect of aerobic and resistance exercise on central hemodynamic responses in severe chronic heart failure. J Appl Physiol 2002, 93:175-180.
36. Conraads V.M., Beckers P., Bosmans J., et al. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 2002, 23:1854-1860.
37. Singh M.A., Ding W., Manfredi T.J., et al. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am J Physiol 1999, 277:E135-E143.
38. Keast M.L., Slovinec D'Angelo M.E., Nelson C.R., et al. Randomized trial of Nordic walking in patients with moderate to severe heart. Can J Cardiol 2013, 29:1470-1476.
39. Guiraud T., Juneau M., Nigam A., et al. Optimization of high intensity interval exercise in coronary heart disease. Eur J Appl Physiol 2010, 108:733-740.
40. Guiraud T., Nigam A., Juneau M., et al. Acute responses to high-intensity intermittent exercise in CHD patients. Med Sci Sports Exerc 2011, 43:211-217.
41. Meyer P., Normandin E., Gayda M., et al. High-intensity interval exercise in chronic heart failure: protocol optimization. J Card Fail 2012, 18:126-133.
42. Meyer P., Gayda M., Juneau M., Nigam A. High-intensity aerobic interval exercise in chronic heart failure. Curr Heart Fail Rep 2013, 10:130-138.
43. Moholdt T., Aamot I.L., Granoien I., et al. Long-term follow-up after cardiac rehabilitation: a randomized study of usual care exercise training versus aerobic interval training after myocardial infarction. Int J Cardiol 2011, 152:388-390.
44. Wisloff U., Stoylen A., Loennechen J.P., et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007, 115:3086-3094.
45. Myers J., Hadley D., Oswald U., et al. Effects of exercise training on heart rate recovery in patients with chronic heart failure. Am Heart J 2007, 153:1056-1063.
46. Karvonen M.J., Kentala E., Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn 1957, 35:307-315.
47. Normandin E., Nigam A., Meyer P., et al. Acute responses to intermittent and continuous exercise in heart failure patients. Can J Cardiol 2013, 29:466-471.
48. Fox K.F., Cowie M.R., Wood D.A., et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001, 22:228-236.
49. Loehr L.R., Rosamond W.D., Chang P.P., Folsom A.R., Chambless L.E. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 2008, 101:1016-1022.
50. Wright R.S., Anderson J.L., Adams C.D., et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011, 57:e215-e367.
51. Shaw L.J., Berman D.S., Maron D.J., et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008, 117:1283-1291.
52. Gheorghiade M., Bonow R.O. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998, 97:282-289.
53. Keogh A.M., Baron D.W., Hickie J.B. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990, 65:903-908.
54. Rizzello V., Poldermans D., Biagini E., et al. Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction. Heart 2009, 95:1273-1277.
55. Wijns W., Vatner S.F., Camici P.G. Hibernating myocardium. N Engl J Med 1998, 339:173-181.
56. Abidov A., Hachamovitch R., Hayes S.W., et al. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study. Circulation 2003, 107:2894-2899.
57. Elhendy A., Sozzi F., van Domburg R.T., et al. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy. Am J Cardiol 2005, 96:469-473.
58. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., Berman D.S. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003, 107:2900-2907.
59. Schuster A., Morton G., Chiribiri A., et al. Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance. J Am Coll Cardiol 2012, 59:359-370.
60. Feola M., Biggi A., Chauvie S., et al. Myocardial scar and insulin resistance predict cardiovascular events in severe ischaemic myocardial dysfunction: a perfusion-metabolism positron emission tomography study. Nucl Med Commun 2008, 29:448-454.
61. Rahimtoola S.H., La C.G., Ferrari R. Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol 2006, 47:978-980.
62. Allman K.C., Shaw L.J., Hachamovitch R., Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002, 39:1151-1158.
63. Cornily J.C., Gilard M., Le G.G., et al. Accuracy of 16-detector multislice spiral computed tomography in the initial evaluation of dilated cardiomyopathy. Eur J Radiol 2007, 61:84-90.
64. Kim W.Y., Danias P.G., Stuber M., et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001, 345:1863-1869.
65. Assomull R.G., Shakespeare C., Kalra P.R., et al. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation 2011, 124:1351-1360.
66. Rahimtoola S.H. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985, 72:V123-V135.
67. Beanlands R.S., Nichol G., Huszti E., et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007, 50:2002-2012.
68. Cortigiani L., Sicari R., Desideri A., et al. Dobutamine stress echocardiography and the effect of revascularization on outcome in diabetic and non-diabetic patients with chronic ischaemic left ventricular dysfunction. Eur J Heart Fail 2007, 9:1038-1043.
69. Greenwood J.P., Maredia N., Younger J.F., et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012, 379:453-460.
70. Bonow R.O., Maurer G., Lee K.L., et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011, 364:1617-1625.
71. Hernandez A.F., Newby L.K., O'Connor C.M. Preoperative evaluation for major noncardiac surgery: focusing on heart failure. Arch Intern Med 2004, 164:1729-1736.
72. Hernandez A.F., Whellan D.J., Stroud S., et al. Outcomes in heart failure patients after major noncardiac surgery. J Am Coll Cardiol 2004, 44:1446-1453.
73. Exner D.V., Birnie D.H., Moe G., et al. Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: evidence and patient selection. Can J Cardiol 2013, 29:182-195.
74. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
75. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150.
76. Dyub A.M., Whitlock R.P., Abouzahr L.L., Cina C.S. Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: a systematic review and meta-analysis. J Card Surg 2008, 23:79-86.
77. Alderman E.L., Bourassa M.G., Cohen L.S., et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990, 82:1629-1646.
78. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med 1984, 311:1333-1339.
79. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988, 319:332-337.
80. Yusuf S., Zucker D., Peduzzi P., et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994, 344:563-570.
81. Tsuyuki R.T., Shrive F.M., Galbraith P.D., Knudtson M.L., Graham M.M. Revascularization in patients with heart failure. CMAJ 2006, 175:361-365.
82. Kunadian V., Zaman A., Qiu W. Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies. Eur J Heart Fail 2011, 13:773-784.
83. Moller C.H., Penninga L., Wetterslev J., Steinbruchel D.A., Gluud C. Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease. Cochrane Database Syst Rev 2012, CD007224.
84. Velazquez E.J., Lee K.L., O'Connor C.M., et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 2007, 134:1540-1547.
85. Velazquez E.J., Lee K.L., Deja M.A., et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011, 364:1607-1616.
86. Doenst T., Cleland J.G., Rouleau J.L., et al. Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease. Circ Heart Fail 2013, 6:443-450.
87. Jones R.H., White H., Velazquez E.J., et al. STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. J Am Coll Cardiol 2010, 56:490-498.
88. Chan K.M., Punjabi P.P., Flather M., et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation 2012, 126:2502-2510.
89. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004, 351:2481-2488.
90. Bigger J.T., Whang W., Rottman J.N., et al. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999, 99:1416-1421.
91. Goldenberg I., Moss A.J., McNitt S., et al. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006, 47:1811-1817.
92. Steinbeck G., Andresen D., Seidl K., et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009, 361:1427-1436.
93. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
94. Connolly S.J., Hallstrom A.P., Cappato R., et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000, 21:2071-2078.
95. Barsheshet A., Goldenberg I., Moss A.J., et al. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial. J Cardiovasc Electrophysiol 2011, 22:1237-1242.
96. Bax J.J., Schinkel A.F., Boersma E., et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004, 110:II18-II22.
97. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
98. Tang A.S., Wells G.A., Talajic M., et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010, 363:2385-2395.
99. Leon A.R., Abraham W.T., Curtis A.B., et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005, 46:2348-2356.
100. Ailawadi G., Lapar D.J., Swenson B.R., et al. Surgically placed left ventricular leads provide similar outcomes to percutaneous leads in patients with failed coronary sinus lead placement. Heart Rhythm 2010, 7:619-625.
101. Penicka M., Bartunek J., Lang O., et al. Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting. J Am Coll Cardiol 2007, 50:1315-1323.
102. Pokushalov E., Romanov A., Prohorova D., et al. Coronary artery bypass grafting with concomitant cardiac resynchronisation therapy in patients with ischaemic heart failure and left ventricular dyssynchrony. Eur J Cardiothorac Surg 2010, 38:773-780.
103. Healey J.S., Merchant R., Simpson C., et al. Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. Can J Cardiol 2012, 28:141-151.
104. Grace S.L., Chessex C., Arthur H., et al. Systematizing inpatient referral to cardiac rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society joint position paper endorsed by the Cardiac Care Network of Ontario. Can J Cardiol 2011, 27:192-199.